Cardiovascular outcome trials in Type 2 diabetes: food for thought

Jadin J Chahade; Ryekjang Kim; John R Ussher

doi:10.2217/fca-2021-0004

Cardiovascular outcome trials in Type 2 diabetes: food for thought

Future Cardiol. 2021 May;17(3):407-410. doi: 10.2217/fca-2021-0004. Epub 2021 Feb 5.

Authors

Jadin J Chahade^{1

2

3}, Ryekjang Kim^{1

2

3}, John R Ussher^{1

2

3}

Affiliations

¹ Faculty of Pharmacy & Pharmaceutical Sciences, University of Alberta, Edmonton, AB, T6G 2H1, Canada.
² Alberta Diabetes Institute, University of Alberta, Edmonton, AB, T6G 2E1, Canada.
³ Mazankowski Alberta Heart Institute, University of Alberta, Edmonton, AB, T6G 2B7, Canada.

PMID: 33543646
DOI: 10.2217/fca-2021-0004

No abstract available

Keywords: cardiovascular outcomes; dipeptidyl peptidase 4 inhibitors; glucagon-like peptide-1 receptor agonists; sodium-glucose cotransporter-2 inhibitors; type 2 diabetes.

Publication types

Editorial
Research Support, Non-U.S. Gov't

MeSH terms

Cardiovascular Diseases* / epidemiology
Diabetes Mellitus, Type 2* / complications
Diabetes Mellitus, Type 2* / drug therapy
Humans
Hypoglycemic Agents

Substances

Hypoglycemic Agents

Grants and funding

Project Grant/CIHR/Canada